KPNA2 and KPNB1

  • Number of citations of the paper that reports this interaction (PMID 9323134)
  • 153
  • Data Source:
  • BioGRID (pull down)
  • HPRD (two hybrid, in vitro)

KPNA2

KPNB1

Gene Name karyopherin alpha 2 (RAG cohort 1, importin alpha 1) karyopherin (importin) beta 1
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 104 interactors: ACTN1 ACTN4 ANKIB1 AP2B1 APOBEC1 APP ARL4A ARL5A BRCA1 BTBD2 CASP2 CCDC107 CDA CDK5RAP3 CHD3 CHEK2 CORO1B CREB3L3 CREBBP CSE1L CSNK1A1 CUL4B DCTN2 DDIT3 EP300 EPB41 FEZ2 FN1 FTH1 GART GMCL1 GRB2 H1F0 HAP1 HMG20A HNRNPC HOMER2 HOMEZ HSPA4 IFT20 IMMT INO80E ITK JUN KLC4 KPNB1 KRT18 KRT40 KRT8 LAMB2 LEF1 LZTS2 MAGED1 MAGEH1 MDFI MLH1 MORC3 MVP MYC NECAB2 NFKBIB NMNAT1 NR3C1 NUP153 NUP50 NUP62 NUTM1 PAX5 PLAG1 PNMA5 PRKD3 PTMA RAG1 RAN RANBP2 RBM48 RBPMS RECQL RELA RELB RGL2 RILP RNMT SART3 SERTAD3 SGK1 SLC2A2 SPRY1 SRPK1 TADA2A TAF3 TAF8 TANK TBPL2 TP53 TRAF1 TRIM54 TSC22D4 TXNIP UBR5 USHBP1 ZBTB7B ZC3H12A ZNF131 59 interactors: AMFR CD99 CHD3 CSE1L CSNK1A1 CUL4B ELAVL1 EXO1 FGFR1 H1F0 HIST1H1C IGFBP3 IGFBP5 IPO7 IPO8 KPNA1 KPNA2 KPNA3 KPNA4 KPNA6 LYST MESDC2 MSL1 NFATC1 NFYA NUP153 NUP50 NUP54 NUP62 NUP98 NUTF2 PIAS4 PLCD1 PRKD3 PTHLH PTMA PTN PTPN2 RAN RANBP1 RANBP2 RCC1 RPL5 RUNX1T1 SMAD2 SMAD3 SMN1 SMNDC1 SNUPN SOX9 SREBF2 SRY TAF3 TAF8 TERF1 TP53 TUBA1A UBR5 VIMP
Entrez ID 3838 3837
HPRD ID 02818 04114
Ensembl ID ENSG00000182481
Uniprot IDs P52292 Q7Z726 B7Z752 B7ZAV6 Q14974
PDB IDs 1EFX 1QGK 1QGR 3FEX 3FEY 4E4V 1F59 1IBR 1M5N 1O6O 1O6P 1QGK 1QGR 2P8Q 2Q5D 2QNA 3LWW
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aggressive  aggressiveness  assembled  attempt  carcinomas  curable  diagnostics  disregarding  eic  emgd  endometrial  entities  figo  immunoreactivity  interplay  introducing  malignancy  mediator  mfe  microarrays  nucleocytoplasmic  precancerous  regimens  surgically  tmas  trp53  tumour  untreatable  uterus 
30d  enhancer  ezh2  forced  homologue  immunohistochemical  importantly  malignancies  mir  mpnst  mpnsts  negatively  nerve  neurofibromatosis  nodes  polycomb  recur  represents  rescues  sheath  signalling  sporadically  suppresses  targetable  tumourigenesis  tumourigenicity  tumours  utr  zeste 
Tagcloud (Difference) ?
aggressive  aggressiveness  assembled  attempt  carcinomas  curable  diagnostics  disregarding  eic  emgd  endometrial  entities  figo  immunoreactivity  interplay  introducing  malignancy  mediator  mfe  microarrays  nucleocytoplasmic  precancerous  regimens  surgically  tmas  trp53  tumour  untreatable  uterus 
30d  enhancer  ezh2  forced  homologue  immunohistochemical  importantly  malignancies  mir  mpnst  mpnsts  negatively  nerve  neurofibromatosis  nodes  polycomb  recur  represents  rescues  sheath  signalling  sporadically  suppresses  targetable  tumourigenesis  tumourigenicity  tumours  utr  zeste 
Tagcloud (Intersection) ?